2025 Technology and Life Sciences PIPE and RDO Report

April 8, 2026 - 00:08

A comprehensive new analysis of private investments in public equity (PIPEs) and registered direct offerings (RDOs) within the technology and life sciences sectors has been released, providing a crucial snapshot of market activity. The report meticulously examines 163 transactions completed during the 2024 calendar year, offering valuable data on deal structures, pricing, and investor participation.

The findings highlight the continued importance of these financing mechanisms for public companies seeking efficient capital. In a climate of market volatility, PIPEs and RDOs offer a strategic alternative to traditional follow-on public offerings, enabling firms to secure funding with potentially less market disruption. The study breaks down trends by industry sub-sector, revealing where investor interest is strongest and how deal terms are evolving in response to current economic conditions.

Legal and financial experts contributed to the analysis, noting that these transactions require careful navigation of regulatory frameworks and market expectations. The report serves as an essential benchmark for executives, investors, and advisors operating in the dynamic technology and life sciences landscapes, providing them with the insights needed to structure future deals effectively.